Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

(Fluorine-18 labeled androgens and progestins; imaging agents for tumors of prostate and breast): Technical progress report, February 1, 1987-January 31, 1988

Technical Report ·
OSTI ID:5963310
This project develops fluorine-18 labeled steroids that possess high binding affinity and selectivity for androgen and progesterone receptors and can be used as positron-emission tomographic imaging agents for prostate tumors and breast tumors, respectively. These novel diagnostic agents may enable an accurate estimation of tumor dissemination, such as metastasis of prostate cancer and lymph node involvement of breast cancer, and an in vivo determination of the endocrine responsiveness of these tumors. They will provide essential information for the selection of alternative therapies thereby improving the management of prostate and breast cancer patients. 14 refs., 1 tab.
Research Organization:
Illinois Univ., Urbana (USA)
DOE Contract Number:
FG02-86ER60401
OSTI ID:
5963310
Report Number(s):
DOE/ER/60401-18; ON: DE88000808
Country of Publication:
United States
Language:
English

Similar Records